BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Mallinckrodt
Daiichi Sankyo
Healthtrust
McKinsey
Fuji
McKesson
Boehringer Ingelheim
Fish and Richardson

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021735

« Back to Dashboard

NDA 021735 describes TERCONAZOLE, which is a drug marketed by Fougera Pharms, Nycomed Us, Taro, and Perrigo New York, and is included in seven NDAs. It is available from ten suppliers. Additional details are available on the TERCONAZOLE profile page.

The generic ingredient in TERCONAZOLE is terconazole. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the terconazole profile page.
Summary for 021735
Tradename:TERCONAZOLE
Applicant:Nycomed Us
Ingredient:terconazole
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Pharmacology for NDA: 021735
Ingredient-typeAzoles
Suppliers and Packaging for NDA: 021735
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TERCONAZOLE terconazole CREAM;VAGINAL 021735 NDA E. FOUGERA & CO. A division of Nycomed US Inc. 0168-0347 0168-0347-20 20 g in 1 TUBE, WITH APPLICATOR (0168-0347-20)
TERCONAZOLE terconazole CREAM;VAGINAL 021735 NDA Pharmaderm, A division of Nycomed US Inc. 0462-0347 0462-0347-20 20 g in 1 TUBE, WITH APPLICATOR (0462-0347-20)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;VAGINALStrength0.8%
Approval Date:Oct 1, 2004TE:BXRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Baxter
Healthtrust
Federal Trade Commission
Novartis
Queensland Health
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot